350.6: The impact of circulating DSA in visceral transplant recipients without histological evidence of rejection: How should we treat or not treat?

MLA

Yasser Fouda, et al. “350.6: The Impact of Circulating DSA in Visceral Transplant Recipients without Histological Evidence of Rejection: How Should We Treat or Not Treat?” Transplantation, vol. 103, July 2019, p. S22. EBSCOhost, https://doi.org/10.1097/01.tp.0000575532.57810.09.

APA

Yasser Fouda, Masato Fujiki, Kareem Abu-Elmagd, Raffaele Girlanda, Aiwen Zhang, Mohammed Osman, Hirak Pahari, & Hajime Matsushima. (2019). 350.6: The impact of circulating DSA in visceral transplant recipients without histological evidence of rejection: How should we treat or not treat? Transplantation, 103, S22. https://doi.org/10.1097/01.tp.0000575532.57810.09

Chicago

Yasser Fouda, Masato Fujiki, Kareem Abu-Elmagd, Raffaele Girlanda, Aiwen Zhang, Mohammed Osman, Hirak Pahari, and Hajime Matsushima. 2019. “350.6: The Impact of Circulating DSA in Visceral Transplant Recipients without Histological Evidence of Rejection: How Should We Treat or Not Treat?” Transplantation 103 (July): S22. doi:10.1097/01.tp.0000575532.57810.09.